Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in H9c2 cells

Molecular and Cellular Biochemistry

Volumn 350, Issue 1-2, 2011, Pages 237-250

  Chiu, Po Yee ^a   Chen, Na ^a   Leong, Po Kuan ^a   Leung, Hoi Yan ^a   Ko, Kam Ming ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Apoptosis; ERK; Glutathione antioxidant system; H9c2; Hypoxia reoxygenation; Nrf2; Schisandrin B

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYTOCHROME P450 INHIBITOR; GLUTATHIONE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SCHIZANDRIN B; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; EX VIVO STUDY; FEMALE; GENETIC TRANSFECTION; NONHUMAN; RAT; REOXYGENATION; REPERFUSION INJURY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CARDIOTONIC AGENTS; CELL LINE; CYCLOOCTANES; CYTOPROTECTION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE KNOCKDOWN TECHNIQUES; GLUTATHIONE; LIGNANS; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; POLYCYCLIC COMPOUNDS; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

RATTUS;

EID: 79953674467     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0703-3     Document Type: Article

References (53)

1. Ko RKM, Mak DHF (2004) Schisandrin B and other dibenzocyclooctadiene lignans. In: Packer L, Halliwel B, Ong CN (eds) Herbal and traditional medicine: molecular aspects of health. Marcel Dekker, New York, pp 289-314
2. Yim TK, Ko KM (1999) Methylenedioxy group and cyclooctadiene ring as structural determinants of schisandrin in protecting against myocardial ischemia-reperfusion injury in rats. Biochem Pharmacol 57:77-81 (Pubitemid 29012497)
3. Yim TK, Ko KM (1999) Schisandrin B protects against myocardial ischemia-reperfusion injury by enhancing myocardial glutathione antioxidant status. Mol Cell Biochem 196:151-156 (Pubitemid 29338790)
4. Chiu PY, Ko KM (2003) Time-dependent enhancement in mitochondrial glutathione status and ATP generation capacity by schisandrin B treatment decreases the susceptibility of rat hearts to ischemia-reperfusion injury. Biofactors 19:43-51 (Pubitemid 38073143)
5. Chiu PY, Leung HY, Siu AH, Poon MK, Ko KM (2007) Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against ischemia-reperfusion injury in rat hearts. Acta Pharmacol Sin 28:1559-1565 (Pubitemid 47493276)
6. Chiu PY, Leung HY, Poon MK, Mak DH, Ko KM (2006) (-)Schisandrin B is more potent than its enantiomer in enhancing cellular glutathione and heat shock protein production as well as protecting against oxidant injury in H9c2 cardiomyocytes. Mol Cell Biochem 289:185-191 (Pubitemid 44322488)
7. Chiu PY, Luk KF, Leung HY, Ng KM, Ko KM (2008) Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and inhibit associated changes in Ca2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes. Life Sci 82:1092-1101
8. Chiu PY, Ko KM (2004) Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats. Mol Cell Biochem 266:139-144 (Pubitemid 39562314)
9. Baek MS, Kim JY, Myung SW, Yim YH, Jeong JH, Kim DH (2001) Metabolism of dimethyl-4,40-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2, 2′-dicarboxylate (DDB) by human liver microsomes: characterization of metabolic pathways and of cytochrome P450 isoforms involved. Drug Metab Dispos 29:381-388 (Pubitemid 32275550)
10. Chen N, Ko M (2010) Schisandrin B-induced glutathione antioxidant response and cardioprotection are mediated by reactive oxidant species production in rat hearts. Biol Pharm Bull 33:825-829
11. D'Autreaux B, Toledano MB (2007) ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8:813-824 (Pubitemid 47462134)
12. Dalton TP, Shertzer HG, Puga A (1999) Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 39:67-101 (Pubitemid 29222552)
13. Lyakhovich VV, Vavilin VA, Zenkov NK, Menshchikova EB (2006) Active defense under oxidative stress. The antioxidant responsive element. Biochemistry (Mosc) 71:962-974
14. McCubrey JA, Lahair MM, Franklin RA (2006) Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8:1775-1789 (Pubitemid 44726351)
15. Torres M, Forman HJ (2003) Redox signaling and the MAP kinase pathways. Biofactors 17:287-296 (Pubitemid 37267162)
16. Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911-1912
17. Dougherty CJ, Kubasiak LA, Prentice H, Andreka P, Bishopric NH, Webster KA (2002) Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. Biochem J 362:561-571 (Pubitemid 34242306)
18. Tanos T, Marinissen MJ, Leskow FC, Hochbaum D, Martinetto H, Gutkind JS, Coso OA (2005) Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J Biol Chem 280:18842-18852 (Pubitemid 41379586)
19. Viktorsson K, Ekedahl J, Lindebro MC, Lewensohn R, Zhivotovsky B, Linder S, Shoshan MC (2003) Defective stress kinase and Bak activation in response to ionizing radiation but not cisplatin in a non-small cell lung carcinoma cell line. Exp Cell Res 289:256-264 (Pubitemid 37117411)
20. Zheng M, Reynolds C, Jo SH, Wersto R, Han Q, Xiao RP (2005) Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury. FASEB J 19:109-111 (Pubitemid 40069934)
21. Crowe DL, Shemirani B (2000) The transcription factor ATF-2 inhibits extracellular signal regulated kinase expression and proliferation of human cancer cells. Anticancer Res 20:2945-2949
22. Echave P, Machado-da-Silva G, Arkell RS, Duchen MR, Jacobson J, Mitter R, Lloyd AC (2009) Extracellular growth factors and mitogens cooperate to drive mitochondrial biogenesis. J Cell Sci 122:4516-4525
23. Ouwens DM, de Ruiter ND, van der Zon GC, Carter AP, Schouten J, van der Burgt C, Kooistra K, Bos JL, Maassen JA, Van Dam H (2002) Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J 21:3782-3793 (Pubitemid 34787051)
24. Zhong CY, Zhou YM, Douglas GC, Witschi H, Pinkerton KE (2005) MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Carcinogenesis 26:2187-2195 (Pubitemid 41672207)
25. Copple IM, Goldring CE, Kitteringham NR, Park BK (2008) The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 246:24-33
26. Eggler AL, Gay KA, Mesecar AD (2008) Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2. Mol Nutr Food Res 52(Suppl 1):S84-S94
27. Owuor ED, Kong AN (2002) Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol 64:765-770 (Pubitemid 35238028)
28. Jeyapaul J, Jaiswal AK (2000) Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma- glutamylcysteine synthetase heavy subunit gene. Biochem Pharmacol 59:1433-1439 (Pubitemid 30177361)
29. Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89-116
30. Liu XP, Goldring CE, Copple IM, Wang HY, Wei W, Kitteringham NR, Park BK (2007) Extract of Ginkgo biloba induces phase 2 genes through Keap1-Nrf2-ARE signaling pathway. Life Sci 80:1586-1591 (Pubitemid 46412359)
31. Zhang Y, Munday R, Jobson HE, Munday CM, Lister C, Wilson P, Fahey JW, Mhawech-Fauceglia P (2006) Induction of GST and NQO1 in cultured bladder cells and in the urinary bladders of rats by an extract of broccoli (Brassica oleracea italica) sprouts. J Agric Food Chem 54:9370-9376 (Pubitemid 46086094)
32. Ko KM, Mak DH, Li PC, Poon MK, Ip SP (1995) Enhancement of hepatic glutathione regeneration capacity by a lignan-enriched extract of Fructus schisandrae in rats. Jpn J Pharmacol 69:439-442 (Pubitemid 26013779)
33. Luk KF, Ko KM, Ng KM (2008) Separation and purification of (-)schisandrin B from schisandrin B stereoisomers. Biochem Eng J 42:55-60
34. Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA (2003) Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol 23:7198-7209 (Pubitemid 37211002)
35. Griffith OW (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106:207-212
36. Erfle H, Neumann B, Rogers P, Bulkescher J, Ellenberg J, Pepperkok R (2008) Work flow for multiplexing siRNA assays by solid-phase reverse transfection in multiwell plates. J Biomol Screen 13:575-580
37. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H (2001) ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2:222-228 (Pubitemid 32273301)
38. Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, McCubrey JA (2003) Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (review). Int J Oncol 22:469-480
39. Yuan X, Xu C, Pan Z, Keum YS, Kim JH, Shen G, Yu S, Oo KT, Ma J, Kong AN (2006) Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells. Mol Carcinog 45:841-850 (Pubitemid 44646336)
40. Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH, Wung BS (2006) Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 78:2889-2897
41. Na HK, Kim EH, Jung JH, Lee HH, Hyun JW, Surh YJ (2008) (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch Biochem Biophys 476:171-177
42. Zipper LM, Mulcahy RT (2003) Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells. Toxicol Sci 73:124-134 (Pubitemid 36609094)
43. Sun Z, Huang Z, Zhang DD (2009) Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS ONE 4:e6588
44. Jain M, Brenner DA, Cui L, Lim CC, Wang B, Pimentel DR, Koh S, Sawyer DB, Leopold JA, Handy DE, Loscalzo J, Apstein CS, Liao R (2003) Glucose-6-phosphate dehydrogenase modulates cytosolic redox status and contractile phenotype in adult cardiomyocytes. Circ Res 93:e9-e16
45. Han D, Hanawa N, Saberi B, Kaplowitz N (2006) Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am J Physiol Gastrointest Liver Physiol 291:G1-G7 (Pubitemid 44024656)
46. Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ (2009) Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Asp Med 30:86-98
47. Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48:749-762
48. Tao L, Gao E, Hu A, Coletti C, Wang Y, Christopher TA, Lopez BL, Koch W, Ma XL (2006) Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress. Br J Pharmacol 149:311-318 (Pubitemid 44453432)
49. Shioji K, Nakamura H, Masutani H, Yodoi J (2003) Redox regulation by thioredoxin in cardiovascular diseases. Antioxid Redox Signal 5:795-802 (Pubitemid 37462063)
50. Das DK, Maulik N (2003) Preconditioning potentiates redox signaling and converts death signal into survival signal. Arch Biochem Biophys 420:305-311 (Pubitemid 37491115)
51. Turoczi T, Chang VW, Engelman RM, Maulik N, Ho YS, Das DK (2003) Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol 35:695-704 (Pubitemid 36677453)
52. Shioji K, Kishimoto C, Nakamura H, Masutani H, Yuan Z, Oka S, Yodoi J (2002) Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 106:1403-1409 (Pubitemid 35013046)
53. Das DK, Maulik N (2004) Conversion of death signal into survival signal by redox signaling. Biochemistry (Mosc) 69:10-17